Find your path to Matthew
150 people in our graph share verified history with Matthew — schools, employers, funds. One of them is your warm intro.
Ryan LoggieunlockedMatthew: together at OrbiMed
×11Matthew: together at OrbiMed
About
Matthew Rizzo heads a royalty and credit team, directed over $6 billion in structured credit and royalty deals, and brings 30 years of healthcare experience including pharma licensing and acquisitions.
Invests in
AI & Machine LearningBiotechHealthtechMedical Devices
Colleagues at OrbiMed
Aldo Brambilla
Associate at Silver Lake Partners
Alexander M. Cooper
Investor at OrbiMed
Anat Naschitz
Executive Officer at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Ava Poole
Investor at Insight Partners
Frequently asked questions
- Who is Matthew Rizzo?
- Matthew Rizzo heads a royalty and credit team, directed over $6 billion in structured credit and royalty deals, and brings 30 years of healthcare experience including pharma licensing and acquisitions.
- Where does Matthew Rizzo work?
- Matthew Rizzo is Partner at OrbiMed.
- What does Matthew Rizzo invest in?
- Matthew Rizzo invests in AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- What check size does Matthew Rizzo write?
- Matthew Rizzo typically writes checks of $1M – $75M.